Pfizer Zoloft recall
Pfizer initiated a Class II recall Oct. 14 of more than 26,000 units of the oral concentrate version of its antidepressant Zoloft (sertraline) produced at its Parsippany, N.Y. plant. "Pouches containing the glass droppers used to dispense the medication may contain small fragments of glass," FDA's MedWatch announced Dec. 14...
You may also be interested in...
Early results from its novel antiviral are encouraging, but demonstrating life-saving qualities in a short window of time will be tricky.
After federal agencies invested almost $5600m to ensure Cue Health could scale up production, FDA announces the self-administered test will be available OTC. it's the agency's first emergency use authorization for an at-home molecular diagnostic test available nonprescription.
Tezepelumab was among four products that the European Medicines Agency most recently considered for review under its accelerated assessment mechanism.